Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Immune Reconstitution After Cord Blood Transplantation in Adults Depends on Activity of Thymic Epithelial Cells and Vascular Endothelial Elements,

Julia Brown, PhD, Haesook T Kim, PhD, Corey Cutler, MD, MPH, FRCPC, Sean McDonough, Edwin Alyea, MD, Vincent Ho, MD, Eyal C. Attar, MD, Bimalangshu R. Dey, MD, Steven L. McAfee, MD, Thomas Spitzer, MD, Robert J Soiffer, MD, Jerome Ritz, MD, Joseph H Antin, MD, Karen K. Ballen, MD, Vassiliki A Boussiotis, MD, PhD

Blood (2011) 118 (21): 4075.

https://doi.org/10.1182/blood.V118.21.4075.4075

Published: 2011

Journal Articles

Hyperlipidemia After Allogeneic Hematopoietic Stem Cell Transplantation.

Bradley W Blaser, MD, PhD, Haesook Kim, PhD, Jorge Plutzky, MD, Edwin Alyea, III, MD, Vincent Ho, MD, Corey Cutler, MD, MPH, Philippe Armand, MD, PhD, John Koreth, MBBS, DPhil, Joseph H. Antin, MD, Robert Soiffer, MD

Blood (2010) 116 (21): 3457.

https://doi.org/10.1182/blood.V116.21.3457.3457

Published: 2010

Journal Articles

GM-CSF Secreting Leukemia Cell Vaccination after Allogeneic Reduced Intensity Hematopoietic Stem Cell Transplantation for Advanced Myeloid Malignancies

Vincent Ho, MD, Glenn Dranoff, MD, Haesook Kim, PhD, Matthew Vanneman, Mildred Pasek, Corey Cutler, MD, John Koreth, MBBS, Edwin Alyea, MD, Joseph H Antin, MD, Ritz Jerome, MD, Robert J Soiffer, MD

Blood (2008) 112 (11): 825.

https://doi.org/10.1182/blood.V112.11.825.825

Published: 2008

Journal Articles

High Rate of Second Malignancies after Reduced Intensity Double Cord Blood Transplants in Adults.

Karen K Ballen, MD, Corey Cutler, MD, Beow Y Yeap, Sc.D, Steven L McAfee, MD, Bimalangshu R Dey, MD, Eyal C Attar, MD, Richard L Haspel, MD, Deborah Liney, BA, John Koreth, MBBS, DPhil, Vincent Ho, MD, Edwin P Alyea, III, MD, Robert J Soiffer, MD, Thomas R Spitzer, MD, Joseph H Antin, MD

Blood (2008) 112 (11): 1958.

https://doi.org/10.1182/blood.V112.11.1958.1958

Published: 2008

Journal Articles

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8 + T Cells.

Julia Brown, PhD, Karen Ballen, MD, Sean McDonough, Xupeng Ge, MD, PhD, Kristen Stevenson, PhD, Haesook Kim, PhD, Carol Reynolds, Bimalangshu R. Dey, MD, PhD, Steve McAfee, MD, Eyal Attar, MD, Thomas Spitzer, MD, Corey Cutler, MD, Vincent Ho, MD, Edwin Alyea, MD, Robert Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD, Vassiliki A. Boussiotis, MD, PhD

Blood (2007) 110 (11): 1057.

https://doi.org/10.1182/blood.V110.11.1057.1057

Published: 2007

Journal Articles

HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults.

Meghan Delaney, DO, Beow Yeap, Sc.D, Richard L. Haspel, MD, PhD, Thomas R. Spitzer, MD, Steven L. McAfee, MD, Bimalangshu Dey, MD, PhD, Eyal Attar, MD, Grace Kao, MD, Edwin Alyea, MD, Stephanie Lee, MD, Corey Cutler, MD, Vincent Ho, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Ballen Karen, MD

Blood (2007) 110 (11): 2032.

https://doi.org/10.1182/blood.V110.11.2032.2032

Published: 2007

Journal Articles

Double Umbilical Cord Blood Transplantation with Reduced Intensity Conditioning and Sirolimus-Based GVHD Prophylaxis.

Corey Cutler, MD, MPH, FRCPC, Rachel Mitrovich, Grace Kao, MD, Vincent Ho, MD, Edwin Alyea, MD, John Koreth, MBBS, Philippe Armand, MD, Bimalangshu Dey, MD, Thomas Spitzer, MD, Robert Soiffer, MD, Joseph H. Antin, MD, Karen Ballen, MD

Blood (2007) 110 (11): 2016.

https://doi.org/10.1182/blood.V110.11.2016.2016

Published: 2007

Journal Articles

GM-CSF Secreting Leukemia Cell Vaccinations after Allogeneic Reduced-Intensity Peripheral Blood Stem Cell Transplantation (SCT) for Advanced Myelodysplastic Syndrome (MDS) or Refractory Acute Myeloid Leukemia (AML).

Vincent Ho, MD, Glenn Dranoff, MD, Haesook Kim, PhD, Mildred Pasek, RN, Corey Cutler, MDMPH, Edwin Alyea, MD, John Koreth, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD

Blood (2006) 108 (11): 3680.

https://doi.org/10.1182/blood.V108.11.3680.3680

Published: 2006

Journal Articles

Effects of Cord Blood Cell Subset Populations in the Development of the Dominant Cord Blood Unit in Non-Myeloablative Sequential Double Cord Blood Transplantation (DCBT).

David T. Ting, MD, Karen Ballen, MD, Thomas R. Spitzer, MD, Richard L. Haspel, MD, Michelle Dorn, Fred Preffer, PhD, Vassiliki Boussiotis, MD PhD, Steven McAfee, MD, Eyal Attar, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD, Corey Cutler, MD MPH, Vincent Ho, MD, Bimalangshu R. Dey, MD

Blood (2006) 108 (11): 3148.

https://doi.org/10.1182/blood.V108.11.3148.3148

Published: 2006

Journal Articles

Long-Term Outcome of Methotrexate-Free GVHD Prophylaxis Using Sirolimus and Tacrolimus in Matched Related (MRD) and Unrelated Donor (URD) Peripheral Blood Stem Cell Transplantation (PBSCT).

Corey Cutler, MD, MPH, FRCP, Shuli Li, MS, Vincent Ho, MD, John Koreth, MBBS, Edwin Alyea, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD

Blood (2006) 108 (11): 757.

https://doi.org/10.1182/blood.V108.11.757.757

Published: 2006

Journal Articles

Outcomes of 40 Adult Patients after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Conditioning Regimen.

Karen K. Ballen, MD, Corey Cutler, MD, Thomas R. Spitzer, MD, Beow Yeap, ScD, Steve McAfee, MD, Bimalangshu R. Dey, MD, Eyal Attar, MD, Richard L. Haspel, MD, PhD, Edwin Alyea, MD, Vincent Ho, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD

Blood (2006) 108 (11): 605.

https://doi.org/10.1182/blood.V108.11.605.605

Published: 2006

Journal Articles

Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population.

Karen K. Ballen, MD, Thomas R. Spitzer, MD, Beow Yeap, ScD, McAfee Steve, MD, Bimalanghsu R. Dey, MD, Eyal Attar, MD, Edwin Alyea, MD, Corey Cutler, MD, Vincent Ho, MD, Stephanie Lee, MD, Robert Soiffer, MD, Joseph H. Antin, MD

Blood (2005) 106 (11): 2048.

https://doi.org/10.1182/blood.V106.11.2048.2048

Published: 2005

Journal Articles

Sirolimus and Tacrolimus without Methotrexate as Graft-vs.-Host Disease Prophylaxis after Matched, Unrelated Peripheral Blood Stem Cell Transplantation: Excellent GVHD Control with Low Transplant-Related Morbidity and Mortality.

Corey Cutler, MD, MPH, FRCP(C), Shuli Li, MS, Haesook T. Kim, PhD, Rebecca Macdonell, Vincent Ho, MD, Edwin Alyea, MD, Stephanie J. Lee, MD, MPH, Robert J. Soiffer, MD, Joseph H. Antin, MD

Blood (2005) 106 (11): 2051.

https://doi.org/10.1182/blood.V106.11.2051.2051

Published: 2005

Journal Articles

High Levels of Early Donor Chimerism and Treatment-Responsive Disease Predict Improved Progression-Free Survival Following Non-Myeloablative Transplantation for Advanced CLL.

Jennifer R. Brown, MD, PhD, Shuli Li, Haesook Kim, PhD, David C. Fisher, MD, Corey Cutler, MD, MPH, Vincent Ho, MD, Stephanie J. Lee, MD, MPH, Jerome Ritz, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD, John G. Gribben, MD, DSC, Edwin P. Alyea, MD

Blood (2005) 106 (11): 560.

https://doi.org/10.1182/blood.V106.11.560.560

Published: 2005

Journal Articles

Sirolimus, Tacrolimus and Reduced-Dose Methotrexate as Graft Versus Host Disease (GVHD)Prophylaxis after Non-Myeloablative Stem Cell Transplantation: Low Incidence of Acute GVHD Compared with Tacrolimus/Methotrexate or Cyclosporine/Prednisone.

Edwin P. Alyea, MD, Shuli Li, MS, Haesook Kim, PhD, Corey Cutler, MD, Vincent Ho, MD, Stephanie J. Lee, MD, John Gribben, MD, PhD, Jerome Ritz, MD, David C. Fisher, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD

Blood (2004) 104 (11): 730.

https://doi.org/10.1182/blood.V104.11.730.730

Published: 2004

Journal Articles

Prevention of Acute GVHD with Sirolimus Does Not Abrogate the Risk of Chronic GVHD.

Corey Cutler, MD, MPH, FRCPC, Shuli Li, MS, Haesook T. Kim, PhD, Edwin Alyea, MD, Vincent Ho, MD, Stephanie J. Lee, MD, MPH, David C. Fisher, MD, Robert Schlossman, MD, David Miklos, MD, Robert Soiffer, MD, Joseph H. Antin, MD

Blood (2004) 104 (11): 3317.

https://doi.org/10.1182/blood.V104.11.3317.3317

Published: 2004

Journal Articles

Oral Mucositis Incidence and Severity after Methotrexate and Non-Methotrexate Containing GVHD Prophylaxis Regimens.

Corey Cutler, MD MPH FRCPC, Shuli Li, MS, Haesook T. Kim, PhD, Patricia Laglenne, MS RD, Colleen Ford, Vincent Ho, MD, Stephanie J. Lee, MD MPH, Edwin Alyea, MD, Robert Soiffer, MD, Joseph H. Antin, MD, Stephen Sonis, DMD DMSc

Blood (2004) 104 (11): 351.

https://doi.org/10.1182/blood.V104.11.351.351

Published: 2004

Journal Articles

Sirolimus and Tacrolimus as Graft-vs.-Host Disease Prophylaxis in Allogeneic Stem Cell Transplantation: The Dana-Farber Cancer Institute Experience.

Corey Cutler, MD MPH FRCPC, Shuli Li, MS, Haesook T. Kim, PhD, Edwin Alyea, MD, Vincent Ho, MD, Stephanie J. Lee, MD MPH, David C. Fisher, MD, Robert Schlossman, MD, David Miklos, MD PhD, Stephen Sonis, DMD DMSc, Robert Soiffer, MD, Joseph H. Antin, MD

Blood (2004) 104 (11): 1227.

https://doi.org/10.1182/blood.V104.11.1227.1227

Published: 2004

Journal Articles

Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis.

Corey Cutler, MD MPH FRCPC, David Miklos, MD PhD, Stephanie J. Lee, MD MPH, Sook-Bin Woo, DMD, Nathaniel Treister, DMD, Don Bienfang, MD, Lloyd Klickstein, MD PhD, Jesse Levin, BA, Katherine H. Miller, BA, Carol Reynolds, PhD, Mildred Pasek, RN, Vincent Ho, MD, Jerome Ritz, MD PhD, Joseph H. Antin, MD, Robert Soiffer, MD, Edwin Alyea, MD

Blood (2004) 104 (11): 2251.

https://doi.org/10.1182/blood.V104.11.2251.2251

Published: 2004

Journal Articles

Sirolimus and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation.

N. Lynn Henry, MD, Shuli Li, MS, Haesook T. Kim, PhD, Colm Magee, MD MPH, Edwin Alyea, MD, Vincent Ho, MD, Stephanie J. Lee, MD MPH, Robert Soiffer, MD, Joseph H. Antin, MD, Corey Cutler, MD MPH FRCPC

Blood (2004) 104 (11): 1834.

https://doi.org/10.1182/blood.V104.11.1834.1834

Published: 2004

NARROW

Immune Reconstitution After Cord Blood Transplantation in Adults Depends on Activity of Thymic Epithelial Cells and Vascular Endothelial Elements,

Hyperlipidemia After Allogeneic Hematopoietic Stem Cell Transplantation.

GM-CSF Secreting Leukemia Cell Vaccination after Allogeneic Reduced Intensity Hematopoietic Stem Cell Transplantation for Advanced Myeloid Malignancies

High Rate of Second Malignancies after Reduced Intensity Double Cord Blood Transplants in Adults.

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8 + T Cells.

HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults.

Double Umbilical Cord Blood Transplantation with Reduced Intensity Conditioning and Sirolimus-Based GVHD Prophylaxis.

GM-CSF Secreting Leukemia Cell Vaccinations after Allogeneic Reduced-Intensity Peripheral Blood Stem Cell Transplantation (SCT) for Advanced Myelodysplastic Syndrome (MDS) or Refractory Acute Myeloid Leukemia (AML).

Effects of Cord Blood Cell Subset Populations in the Development of the Dominant Cord Blood Unit in Non-Myeloablative Sequential Double Cord Blood Transplantation (DCBT).

Long-Term Outcome of Methotrexate-Free GVHD Prophylaxis Using Sirolimus and Tacrolimus in Matched Related (MRD) and Unrelated Donor (URD) Peripheral Blood Stem Cell Transplantation (PBSCT).

Outcomes of 40 Adult Patients after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Conditioning Regimen.

Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population.

Sirolimus and Tacrolimus without Methotrexate as Graft-vs.-Host Disease Prophylaxis after Matched, Unrelated Peripheral Blood Stem Cell Transplantation: Excellent GVHD Control with Low Transplant-Related Morbidity and Mortality.

High Levels of Early Donor Chimerism and Treatment-Responsive Disease Predict Improved Progression-Free Survival Following Non-Myeloablative Transplantation for Advanced CLL.

Sirolimus, Tacrolimus and Reduced-Dose Methotrexate as Graft Versus Host Disease (GVHD)Prophylaxis after Non-Myeloablative Stem Cell Transplantation: Low Incidence of Acute GVHD Compared with Tacrolimus/Methotrexate or Cyclosporine/Prednisone.

Prevention of Acute GVHD with Sirolimus Does Not Abrogate the Risk of Chronic GVHD.

Oral Mucositis Incidence and Severity after Methotrexate and Non-Methotrexate Containing GVHD Prophylaxis Regimens.

Sirolimus and Tacrolimus as Graft-vs.-Host Disease Prophylaxis in Allogeneic Stem Cell Transplantation: The Dana-Farber Cancer Institute Experience.

Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis.

Sirolimus and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only